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Preliminary evidence suggests that inter-individual variability in gut microbiota response 
to a dietary intervention is influenced by baseline gut microbiota composition. Differing 
habitual dietary intakes lead to distinctions in baseline gut microbiota composition 
making it plausible that habitual dietary intake may also influence gut microbiota 
response. Prior to conducting this research no studies had been undertaken to determine 
whether habitual dietary intake has an impact on gut microbiota responsiveness. 
Therefore, the aim of this research was to investigate the influence habitual dietary intake 
has on gut microbiota response to a dietary intervention.  
 Initially, secondary data analysis was conducted to determine whether there was 
any support for the hypothesis that individuals with differing habitual dietary intakes 
would have gut microbiota that respond in a distinctive manner to a dietary intervention. 
The secondary data analysis results demonstrated that dietary groups rich in dietary fibre 
had the greatest impact on gut microbiota responsiveness. An in vitro three-stage colonic 
model system study was conducted to determine whether media with differing 
fermentable carbohydrate (i.e. dietary fibre) contents influenced gut microbiota response 
to an inulin-type fructan prebiotic. It was demonstrated that differing prebiotic driven 
changes in organic acids and bacterial taxa occurred between the low (LFC) and high 
fermentable carbohydrate (HFC) content media. The results of the secondary data 
analysis and in vitro study provided evidence to suggest that a human intervention study 
was warranted. A randomised, double-blind, placebo-controlled, cross-over, human 
intervention study in 34 healthy participants was undertaken to determine whether 
habitual dietary fibre intake influenced gut microbiota response to an inulin-type fructan 





dietary fibre (LDF) group harboured gut microbiota that were less responsive to the 
inulin-type fructan prebiotic than the high habitual dietary fibre (HDF) group.  
 Future studies which aim to modulate the gut microbiota via dietary change or to 
determine the prebiotic potential of a novel fermentable substrate should take habitual 
dietary fibre intakes into consideration when recruiting participants or analysing the data. 
This will help reduce the confounding influence of inter-individual variability in gut 
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